Join
Live feed
·
INSIDERFilingvia Quantisnow
Seelos Therapeutics Inc. logo

Golembiewski Michael Joseph bought $100,222 worth of shares (83,000 units at $1.21), increasing direct ownership by 2,406% to 86,450 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SEEL· Seelos Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SEEL (Seelos Therapeutics Inc.) and more on Quantisnow.